Clinical Trials
60 trialsVICTORIE
Pfizer
PINPOINT
University of Dublin, Trinity College
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
Beijing Chao Yang Hospital
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
The First Hospital of Jilin University
CLOVER
Infanta Leonor University Hospital
Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer
University Of Perugia
The Correlation Between Circulatory Tumor Cells and Venous Thrombosis
Chang Gung Memorial Hospital
BRAVE-Cyclin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CARDIO-COM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT
IRCCS Azienda Ospedaliero-Universitaria di Bologna
GynCAT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer Patients
Chongqing University Cancer Hospital
CONTEST
University of Aarhus
LIFE - Lung Cancer, Immunotherapy, Frailty, Effect
University of Southern Denmark
Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery
Pirogov Russian National Research Medical University
PaTR-VTE
University of Thessaly
Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO
Centre Hospitalier Universitaire de Saint Etienne
REDUCE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
GCTHCM
Tianjin Medical University General Hospital
THRIMM
University Medical Center Groningen
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer
University of Vermont
Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Ottawa Hospital Research Institute
H2H-OSCAR-US
Bayer
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Tumor-educated Platelets in Venous Thromboembolism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
PRACTISE
Bayer
ROADMAP-MM
University of Athens
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection
McMaster University
Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort Study
Beijing Friendship Hospital
HEMOBREAST
University Hospital, Geneva
FIIT_Score
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
VENETIA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Venous Thromboembolism in Advanced Gastric Cancer Patients
Asan Medical Center
PREDICARE
LEO Pharma
Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans
M.D. Anderson Cancer Center
Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism
Danderyd Hospital
Venous Thromboembolic Complications in Ovarian Cancer
Aalborg University Hospital
Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban
Bayer
RIVAL
Guangdong Provincial People's Hospital
AlloTC
Assistance Publique - Hôpitaux de Paris
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
Gruppo Italiano Malattie EMatologiche dell'Adulto
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
LEO Pharma
aXa
Assistance Publique - Hôpitaux de Paris
A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery
St. Olavs Hospital
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
GlaxoSmithKline
REMARK
Ottawa Hospital Research Institute
Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease
Delos Clinical
The Roles of Tissue Factor in Malignant Gliomas
Ontario Clinical Oncology Group (OCOG)
CARMEN
Floralis